Autoimmune Type 1 Diabetes
In this chapter, the authors summarize the current knowledge of possible trigger(s) of p-cell autoimmunity and factors affecting the progression to the clinical onset in individuals who have developed one or more p-cell autoantibodies. Testing islet autoantibodies at random or in select populations such as schoolchildren should inform about the epidemiology of autoimmune islet disease and what to
